Editorial Article
CMC has a knowledge-continuity problem, not a data problem
Connected data and traceable decisions are becoming vital in a new era of pharmaceutical development, AI, and advanced therapies
Through extensive research, experimentation, and clinical trials, experts in the field of drug discovery and development identify promising biopharmaceutical or pharmaceutical drug candidates, optimize their efficacy and safety profiles, and navigate regulatory processes for eventual market approval. From innovative therapies to groundbreaking treatments, this dynamic scientific field plays a pivotal role in revolutionizing medicine and saving lives.
Connected data and traceable decisions are becoming vital in a new era of pharmaceutical development, AI, and advanced therapies